Nicholas A.J. Botwood

Insider Reports History

Location
C/O Syndax Pharmaceuticals, Inc., 730 3 Rd Avenue, Floor 9, New York, NY
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas A.J. Botwood:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Head of R&D, CMO Common Stock 35.2K $316K $9.00 May 16, 2025 Direct

Insider Reports Filed by Nicholas A.J. Botwood

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNDX Syndax Pharmaceuticals Inc May 16, 2025 1 $106K 4 May 19, 2025 Head of R&D, CMO
SNDX Syndax Pharmaceuticals Inc May 12, 2025 0 $0 3 May 16, 2025 Head of R&D, CMO